))
The New Faces of Houston Biotech _ e.052
Manage episode 414333470 series 3006114
Contenuto fornito da John Flavin. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da John Flavin o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
In this episode of "Lab Rats to Unicorns," recorded at TMC's Helix Park in Houston during a Portal Pours event, we're joined by a distinguished panel led by featured host Ritu Shah, a seasoned expert in the biopharma industry and Managing Director at Portal Innovations. The conversation features:
- Sarah Hein, the visionary founding CEO of March Biosciences, a trailblazer in clinical-stage cell-therapy, with a rich background in cancer therapeutics and antibody therapeutics platform technologies.
- Rahul Aras, a dedicated executive with a robust 15+ years in the pharma/biotech sector, currently leading the charge in early-stage technology advancement and business development, recognized for his role at Iterion Therapeutics.
- Michael Torres, an entrepreneur with a fervent mission to turn science into medicine, leveraging his experience in biotech company formation and equity research to make significant strides at Crossbridge Biotech.
Together, they delve into the dynamics of Houston's biotech ecosystem, sharing their unique perspectives on innovation, the challenges of startup culture, and the path forward in transforming patient care.
61 episodi
Condividi
